Renal insufficiency, bleeding and prescription of discharge medication in patients undergoing percutaneous coronary intervention in the National Heart, Lung, and Blood Institute (NHLBI) Dynamic Registry.
Document Type
Article
Publication Date
7-1-2016
Abstract
AIMS: To establish the relationship between renal insufficiency, bleeding and prescription of cardiovascular medication.
METHODS AND RESULTS: This was a prospective, multi-center, cohort study of consecutive patients undergoing PCI during three NHLBI Dynamic Registry recruitment waves. Major and minor bleeding, access site bleeding and rates of prescription of cardiovascular medication at discharge were determined based on estimated glomerular filtration rate (eGFR). Renal insufficiency was an independent predictor of major adverse cardiovascular events (MACE). Bleeding events and access site bleeding requiring transfusion were significantly associated with degrees of renal insufficiency (p
CONCLUSIONS: Renal insufficiency is associated with bleeding in patients undergoing PCI. Patients with renal insufficiency are less likely to receive recommended discharge pharmacotherapy.
Publication Title
Cardiovasc Revasc Med
ISSN
1878-0938
Volume
17
Issue
5
First Page
302
Last Page
307
Recommended Citation
Maree, Andrew O; Ronan J Margey; Faith Selzer; Amrit Bajrangee; Hani Jneid; Oscar C Marroquin; Suresh R Mulukutla; Warren K Laskey; and Alice K Jacobs.
"Renal insufficiency, bleeding and prescription of discharge medication in patients undergoing percutaneous coronary intervention in the National Heart, Lung, and Blood Institute (NHLBI) Dynamic Registry.."
Cardiovasc Revasc Med
